p. 661 - 662
(2007/10/02)p. 4815 - 4818
(2007/10/02)p. 1159 - 1161
(2007/10/02)p. 159 - 165
(2007/10/02)phenyllithium
dihydrocholesterone
(5S,8R,9S,10S,13R,14S,17R)-17-((R)-1,5-Dimethyl-hexyl)-10,13-dimethyl-3-phenyl-hexadecahydro-cyclopenta[a]phenanthren-3-ol
sodium tetraphenyl borate
3α-hydroxy-10.13-dimethyl-17β-((R)-1.5-dimethyl-hexyl)-3β-phenyl-5α-gonane
2α.3α-Dibrommethylen-3β-phenyl-cholestan
(R)-2-Hydroxy-2-phenyl-butyric acid (2R,3S,5S,8R,9S,10S,13R,14S,17R)-17-((R)-1,5-dimethyl-hexyl)-10,13-dimethyl-3-phenyl-hexadecahydro-cyclopenta[a]phenanthren-2-yl ester
Oxo-phenyl-acetic acid (2R,3S,5S,8R,9S,10S,13R,14S,17R)-17-((R)-1,5-dimethyl-hexyl)-10,13-dimethyl-3-phenyl-hexadecahydro-cyclopenta[a]phenanthren-2-yl ester
3β-Phenyl-5α-cholestan-2α-ol